A clinical study to assess the effectiveness of Tanduliyak Yoga in heavy menstrual bleeding during puberty.

A RANDOMIZED OPEN CONTROLLED CLINICAL TRIAL TO ASSESS THE ADD ON EFFECT OF TANDULIYAK YOGA IN THE MANAGEMENT OF TARUNI ASRUGDAR W.S.R. TO PUBERTY MENORRHAGIA - NIL

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/02/103201

Enrollment

Registered

2026-02-06

Start date

Unknown

Completion date

Unknown

Last updated

2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N922- Excessive menstruation at puberty

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1) Patients with prolonged cycle more than 7 days & excessive bleeding per vagina i.e 3 large sized Stayfree secure pads in 24 hours during menstruation. 2) Onset of menarche not exceeding more than 2 years at the time of registration. 3) Polymenorrhagia 4) Inter-menstrual bleeding (Anruta artava- Chakradatta) 5) Patients with Hb 9 to 11 gm/dl 6) Patients with BMI between 18-28 7) Age- 10 to 16 years unmarried girls irrespective of caste, socio-economic status.

Exclusion criteria

Exclusion criteria: 1)Physical examination suggestive of hirsuitism, acanthosis nigricans. 2) BMI more than 28 3) Known case of Endocrinal Disorder like Hypo or Hyperthyroidism, PCOS . 4) Known case of Bleeding Dyscrasias 5) Known case of Pelvic organ pathology 6)Known case of systemic disorders.

Design outcomes

Primary

Measure	Time frame
To evaluate the add on effect of Tanduliyak Yoga along with Reassurance and Ferrous ascorbate in the management of Taruni asrugdar w.s.r. to Puberty Menorrhagia.Timepoint: 90 days	—

Secondary

Measure	Time frame
1) To reduce the amount of bleeding due to menorrhagia.Timepoint: 90 days;2) To assess the improvement by parameters of PBAC.Timepoint: 90 days;3) To reduce the duration of menstrual cycle due to menorrhagia.Timepoint: 90 days;4) To study the etio-pathology of Asrugdara & Puberty menorrhagia in detail.Timepoint: 90 days;5) To assess the improvement in other assessment parameters (with/without clots, angamarda,etc)Timepoint: 90 days;6) To achieve the outcome of study in 90 days (3 menstrual cycles) bu assessment of the conditon in each cycle.Timepoint: 90 days;7) To assure post treatment cycles are symptom free.Timepoint: 90 days	—

Measure

Time frame

1) To reduce the amount of bleeding due to menorrhagia.Timepoint: 90 days;2) To assess the improvement by parameters of PBAC.Timepoint: 90 days;3) To reduce the duration of menstrual cycle due to menorrhagia.Timepoint: 90 days;4) To study the etio-pathology of Asrugdara & Puberty menorrhagia in detail.Timepoint: 90 days;5) To assess the improvement in other assessment parameters (with/without clots, angamarda,etc)Timepoint: 90 days;6) To achieve the outcome of study in 90 days (3 menstrual cycles) bu assessment of the conditon in each cycle.Timepoint: 90 days;7) To assure post treatment cycles are symptom free.Timepoint: 90 days

—

Countries

India

Contacts

Public ContactDr Priya Namonarayan Mishra

Yashwant ayurvedic college postgraduate training and research centre

vishalaturlapati@gmail.com9960217429

Outcome results